References
-
1) A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity.
-
2) Overexpression of TOLLIP Protects against Acute Kidney Injury after Paraquat Intoxication through Inhibiting NLRP3 Inflammasome Activation Modulated by Toll-Like Receptor 2/4 Signaling.
-
3) Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
-
4) Electroacupuncture improves neuronal plasticity through the A2AR/cAMP/PKA signaling pathway in SNL rats.
-
5) Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of Clusterin.
-
6) Activating transcription factor 4 regulates angiogenesis under lipid overload via methionine adenosyltransferase 2A‐mediated endothelial epigenetic alteration.
-
7) Hair growth predicts a depression-like phenotype in rats as a mirror of stress traceability.
-
8) Decabromodiphenyl ethane exposure damaged the asymmetric division of mouse oocytes by inhibiting the inactivation of cyclin-dependent kinase 1.
-
9) Alterations in mitochondrial biogenesis and respiratory activity, inflammation of the senescence-associated secretory phenotype, and lipolysis in the perirenal fat and liver of rats following lifelong exercise and detraining.
-
10) Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice.
-
11) CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
-
12) Autophagy inhibition facilitates wound closure partially dependent on the YAP/IL-33 signaling in a mouse model of skin wound healing.
-
13) Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway.
-
14) Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma.
-
15) Loss of FGFR3 accelerates bone marrow suppression-induced hematopoietic stem and progenitor cell expansion by activating FGFR1-ELK1-Cyclin D1 signaling.